3 The most frequently reported adverse events were nausea, diarrhea, vomiting, constipation, abdominal pain, headache and fatigue
Tirzepatide (Mounjaro), a once-weekly injectable dual GIP and GLP-1 receptor agonist, has been recently approved in India for the treatment of Type 2 Diabetes Mellitus
This serum works on multiple levels while keeping your hydration levels balanced and ensuring you arent overly dried out, which can trigger breakouts
Given recent advances in our understanding of metformin transport in the gut, the incretin system, the potential gutbrain axis and the complexities of the microbiome, more research in these areas would doubtless further improve our knowledge and understanding of metformin action and tolerance
Negative reviews frequently report skin irritation, rashes, blisters, and no change in weight